Skip to main content
Log in

Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Cyclooxygenase-2 (COX-2) enzyme increases abnormally during excitotoxicity and cerebral ischemia and promotes neurotoxicity. Although COX-2 inhibitors could be beneficial, they have significant side effects. We and others have shown that the EP1 receptor is important in mediating PGE2 toxicity. Here, we tested the hypothesis that pretreatment with a highly selective EP1 receptor antagonist, ONO-8713, would improve stroke outcome and that post-treatment would attenuate NMDA-induced acute excitotoxicity and protect organotypic brain slices from oxygen-glucose deprivation (OGD)-induced toxicity. Male C57BL/6 mice were injected intracerebroventricularly with ONO-8713 before being subjected to 90-min middle cerebral artery occlusion (MCAO) and 96-h reperfusion. Significant reduction in infarct size was observed in groups given 0.1 (25.9 ± 4.7%) and 1.0 nmol (27.7 ± 2.8%) ONO-8713 as compared with the vehicle-treated control group. To determine the effects of ONO-8713 post-treatment on NMDA-induced excitotoxicity, mice were given a unilateral intrastriatal NMD A injection followed by one intraperitoneal injection of 10 µg/kg ONO-8713, 1 and 6 h later. Significant attenuation of brain damage (26.6 ± 4.9%) was observed at 48 h in the ONO-8713-treated group. Finally, brain slice cultures were protected (25.5 ± 2.9%) by the addition of ONO-8713 to the medium after OGD. These findings support the notion that the EP1 receptor propagates neurotoxicity and that selective blockade could be considered as a potential preventive and/or therapeutic tool against isch-emic/hypoxic neurological conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abe T, A Kunz, M Shimamura, P Zhou, J Anrather and C Iadecola (2008) The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.J. Cereb. Blood Flow Metab. doi:10.1038/jcbfm.2008.88. In press.

  • Adams J, Y Collaco-Moraes and J de Belleroche (1996) Cyclooxygenase-2 induction in cerebral cortex: an intracel-lular response to synaptic excitation.J. Neurochem. 66, 6–13.

    Article  CAS  PubMed  Google Scholar 

  • Ahmad AS, H Zhuang, V Echeverria and S Doré (2006a) Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity.J. Neurotrauma 23, 1895–1903.

    Article  PubMed  Google Scholar 

  • Ahmad AS, S Saleem, M Ahmad and S Doré (2006b) Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.Toxicol. Sci. 89, 265–270.

    Article  CAS  PubMed  Google Scholar 

  • Ahmad M, S Saleem, H Zhuang, AS Ahmad, V Echeverria, A Sapirstein and S Doré (2006c) 1-HydroxyPGE1 reduces infarction volume in mouse transient cerebral ischemia. Eur.J. Neurosci. 23, 35–42.

    Google Scholar 

  • Baron JA, RS Sandler, RS Bresalier, A Lanas, DG Morton, R Riddell, ER Iverson and DL Demets (2008) Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.Lancet 372(9651), 1756–1764. Epub 2008 Oct 14.

    Article  CAS  PubMed  Google Scholar 

  • Bresalier RS, RS Sandler, H Quan, JA Bolognese, B Oxenius, K Horgan, C Lines, R Riddell, D Morton, A Lanas, MA Konstam, JA Baron and the Adenomatous Polyp Prevention on Vioxx Trial I (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.N. Engl. J. Med. 352, 1092–1102.

    Article  CAS  PubMed  Google Scholar 

  • Doré S, T Otsuka, T Mito, N Sugo, T Hand, L Wu, PD Hurn, RJ Traystman and K Andreasson (2003) Neuronal overex-pression of cyclooxygenase-2 increases cerebral infarction.Ann.Neurol. 54, 155–162.

    Article  PubMed  CAS  Google Scholar 

  • Echeverria V, A Clerman and S Doré (2005) Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure.Eur. J. Neurosci. 22, 2199–2206.

    Article  PubMed  Google Scholar 

  • Florea SM and LA Blatter (2008) The effect of oxidative stress on Ca2+ release and capacitative Ca2+ entry in vascular endothelial cells.Cell Calcium 43, 405–415.

    Article  CAS  PubMed  Google Scholar 

  • Gendron TF, E Brunette, JS Tauskela and P Morley (2005) The dual role of prostaglandin E2 in excitotoxicity and precondi-tioning-induced neuroprotection.Eur. J. Pharmacol. 517, 17–27.

    Article  CAS  PubMed  Google Scholar 

  • Graham DJ, D Campen, R Hui, M Spence, C Cheetham, G Levy, S Shoor and WA Ray (2005) Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.The Lancet 365, 475–481.

    CAS  Google Scholar 

  • Kawahara H, A Sakamoto, S Takeda, H Onodera, J Imaki and R Ogawa (2001) A prostaglandin E2 receptor subtype EP1 receptor antagonist (ONO-8711) reduces hyperalgesia, allo-dynia, and c-fos gene expression in rats with chronic nerve constriction.Anesth. Analg. 93, 1012–1017.

    Article  CAS  PubMed  Google Scholar 

  • Kawano T, J Anrather, P Zhou, L Park, G Wang, KA Frys, A Kunz, S Cho, M Orio and C Iadecola (2006) Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotox-icity.Nat. Med. 12, 225–229.

    Article  CAS  PubMed  Google Scholar 

  • Kobayashi T and S Narumiya (2002) Function of prostanoid receptors: studies on knockout mice.Prostaglandins Other Lipid Mediat. 68–69, 557–573.

    Article  PubMed  Google Scholar 

  • Manevich Y, A Al-Mehdi, V Muzykantov and AB Fisher (2001) Oxidative burst and NO generation as initial response to ischemia in flow-adapted endothelial cells.Am. J. Physiol. Heart Circ. Physiol. 280, H2126-H2135.

    CAS  PubMed  Google Scholar 

  • Matsuo M, N Yoshida, M Zaitsu, K Ishii and Y Hamasaki (2004) Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.J. Neuro-Oncology 66, 285–292.

    Article  Google Scholar 

  • McCullough L, L Wu, N Haughey, X Liang, T Hand, Q Wang, RM Breyer and K Andreasson (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.J. Neurosci. 24, 257–268.

    Article  CAS  PubMed  Google Scholar 

  • Minami T, I Nishihara, R Uda, S Ito, M Hyodo and O Hayaishi (1994) Involvement of glutamate receptors in allodynia induced by prostaglandins E2 and F injected into conscious mice.Pain 57, 225–231.

    Article  CAS  PubMed  Google Scholar 

  • Nagayama M, K Niwa, T Nagayama, ME Ross and C Iadecola (1999) The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.J. Cereb. Blood Flow Metab. 19, 1213–1219.

    Article  CAS  PubMed  Google Scholar 

  • Nakayama M, K Uchimura, RL Zhu, T Nagayama, ME Rose, RA Stetler, PC Isakson, J Chen and SH Graham (1998) Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.Proc. Natl. Acad. Sci. USA 95, 10954–10959.

    Article  CAS  PubMed  Google Scholar 

  • Nakayama Y, K Omote, T Kawamata and A Namiki (2004a) Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.Brain Res. 1010, 62–68.

    Article  CAS  PubMed  Google Scholar 

  • Nakayama Y, K Omote, T Kawamata and A Namiki (2004b) Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.Brain Res. 1010, 62–68.

    Article  CAS  PubMed  Google Scholar 

  • Narumiya S, Y Sugimoto and F Ushikubi (1999) Prostanoid receptors: structures, properties, and functions.Physiol. Rev. 79, 1193–1226.

    CAS  PubMed  Google Scholar 

  • Oka K, T Oka and T Hori (1998a) PGE2 receptor subtype EP1 antagonist may inhibit central interleukin-l β-induced fever in rats.Am. J. Physiol. Regul. Integr. Comp. Physiol. 275, R1762-R1765.

    CAS  Google Scholar 

  • Oka K, T Oka and T Hori (1998b) PGE2 receptor subtype EP1 antagonist may inhibit central interleukin-l β-induced fever in rats.Am. J. Physiol. 275, R1762-R1765.

    CAS  PubMed  Google Scholar 

  • Oka T (2004) Prostaglandin E2 as a mediator of fever: the role of prostaglandin E (EP) receptors.Front. Biosci. 9, 3046–3057.

    Article  CAS  PubMed  Google Scholar 

  • Omote K, H Yamamoto, T Kawamata, Y Nakayama and A Namiki (2002) The effects of intrathecal administration of an antagonist for prostaglandin E receptor subtype EP1 on mechanical and thermal hyperalgesia in a rat model of postoperative pain.Anesth. Analg. 95, 1708–1712.

    Article  CAS  PubMed  Google Scholar 

  • Sakai M, T Minami, N Hara, I Nishihara, H Kitade, Y Kamiyama, K Okuda, H Takahashi, H Mori and S Ito (1998) Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2.Br. J. Pharmacol. 123, 890–894.

    Article  CAS  PubMed  Google Scholar 

  • Saleem S, R Li, G Wei and S Doré (2007) Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice.J. Neurosci. Res. 85, 2433–2440.

    Article  CAS  PubMed  Google Scholar 

  • Salvador Moncada JPB (2006) Nitric oxide, cell bioenergetics and neurodegeneration.J. Neurochem. 97, 1676–1689.

    Article  CAS  Google Scholar 

  • Stock JL, K Shinjo, J Burkhardt, M Roach, K Taniguchi, T Ishikawa, HS Kim, PJ Flannery, TM Coffman, JD McNeish and LP Audoly (2001) The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure.J. Clin. Invest. 107, 325–331.

    Article  CAS  PubMed  Google Scholar 

  • Stoppini L, PA Buchs and D Muller (1991) A simple method for organotypic cultures of nervous tissue.J. Neurosci. Meth. 37, 173–182.

    Article  CAS  Google Scholar 

  • Takadera T and T Ohyashiki (2006) Prostaglandin E2 deteriorates N-methyl-D-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons.Life Sci. 78, 1878–1883.

    Article  CAS  PubMed  Google Scholar 

  • Urushitani M, T Nakamizo, R Inoue, H Sawada, T Kihara, K Honda, A Akaike and S Shimohama (2001) N-methyl-D-aspartate receptor-mediated mitochondrial Ca2+ overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca2+ influx.J. Neurosci. Res. 63, 377–387.

    Article  CAS  PubMed  Google Scholar 

  • Walch L, E Clavarino and PL Morris (2003) Prostaglandin (PG) FP and EP1 receptors mediate PGF and PGE2 regulation of interleukin-l β expression in Leydig cell progenitors.Endocrinology 144, 1284–1291.

    Article  CAS  PubMed  Google Scholar 

  • Watanabe K, T Kawamori, S Nakatsugi, T Ohta, S Ohuchida, H Yamamoto, T Maruyama, K Kondo, S Narumiya, T Sugimura and K Wakabayashi (2000) Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice.Cancer Lett. 156, 57–61.

    Article  CAS  PubMed  Google Scholar 

  • Zhou P, L Qian, T Chou and C Iadecola (2008) Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway.Neurobiol. Dis. 29, 543–551.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sylvain Doré.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahmad, A.S., Kim, Y.T., Ahmad, M. et al. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation. neurotox res 14, 343–351 (2008). https://doi.org/10.1007/BF03033858

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033858

Keywords

Navigation